Scientists develop antidote to new anticoagulants
(Medical Xpress)—Anticoagulants have saved the lives of those at risk for heart attack or stroke. However, because they prevent blood clotting, they can be dangerous to patients who suffer traumatic injuries or who require ...
Medical research
Mar 05, 2013 |
5 / 5 (2) |
0
|
Newly approved blood thinner may increase susceptibility to some viral infections
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral ...
Medical research
Apr 01, 2013 |
not rated yet |
0
|
Do blood thinners + stroke treatment = danger? Study indicates the risk is low
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
Cardiology
Mar 13, 2013 |
not rated yet |
0
|
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
Bristol-Myers, Pfizer's Eliquis approved in Japan
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications
Dec 26, 2012 |
not rated yet |
0
New blood thinner may help prevent leg clots, study finds
(HealthDay)—The new anti-clotting drug apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds.
Medications
Dec 10, 2012 |
5 / 5 (3) |
0
|
Study examines anticoagulation treatment following aortic valve replacement
Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that patients who had warfarin therapy ...
Cardiology
Nov 27, 2012 |
not rated yet |
0
|
Clot-busting medicine safe for use in warfarin-treated patients following stroke
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI). This ...
Cardiology
Jun 26, 2012 |
not rated yet |
0
|
Quick-reversal method may be at hand for new blood thinner
(HealthDay) -- Newer blood-thinning drugs sometimes have one drawback: In cases where they trigger bleeding, their effects can be tough to reverse compared to the standard anticoagulant, warfarin.
Medications
Jun 20, 2012 |
not rated yet |
0
|
Aspirin may prevent recurrence of deep vein blood clots
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...
Medications
May 23, 2012 |
not rated yet |
2
|
Researchers find safer way to use common but potentially dangerous medication
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially ...
Medical research
Feb 29, 2012 |
3 / 5 (1) |
0
|
Blood clot risk halved for patients checking their own Warfarin dose
(Medical Xpress) -- Patients who monitor their own treatment with warfarin or other blood-thinning drugs reduce their risk of developing blood clots by half, an Oxford University study has found.
Diseases, Conditions, Syndromes
Dec 01, 2011 |
not rated yet |
0
|
Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives
A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in ...
Medical research
Aug 28, 2011 |
5 / 5 (3) |
1
|
Study shows ability of new agent to prevent strokes in patients with atrial fibrillation
In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting ...
Cardiology
Aug 10, 2011 |
3 / 5 (1) |
0
Pharmacist-directed anticoagulation service can impact patient satisfaction
As hospitals look for ways to improve patient satisfaction and boost their Medicare reimbursement, a Henry Ford Hospital study found that an inpatient pharmacist-directed anticoagulation service (PDAS) might be an unexpected ...
Health
May 10, 2013 |
not rated yet |
0
